Back

Tailoring long-term anticoagulation to cancer-associated VTE: what does API-CAT tell us?

30 August 2025 (15:40 - 15:50)
Organised by: Logo
Congress Presentation Part of: Rethinking cancer-associated venous thromboembolism (VTE): integrating evidence into practice Venous Thromboembolism ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Isabelle MAHE

Paris Cite University, Paris (France)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Doctor A. Cohen (London, GB)
Slides
Presentation thumbnail
Guiding practice: risk assessment models in cancer-associated VTE
Doctor A. Munoz Martin (Madrid, ES)
Slides
Presentation thumbnail
Managing cancer-associated VTE: what have we learned from CARAVAGGIO?
Doctor A. Cohen (London, GB)
Slides
Presentation thumbnail
Q&A and close
Doctor A. Cohen (London, GB) Doctor A. Munoz Martin (Madrid, ES) Professor I. MAHE (Paris, FR)
Slides

Access the full session

Session thumbnail
Rethinking cancer-associated venous thromboembolism (VTE): integrating evidence into practice
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 15:40 CET
You may be interested in
thumbnail
Congress Presentation
Long-term anticoagulation for pulmonary embolism in a patient with cancer?
20 June 2026
thumbnail
Congress Presentation
Comparative characteristics of anticoagulants used in cancer-associated thrombosis
20 June 2025
thumbnail
Congress Session
Don’t forget to look right
18 May 2025
thumbnail
Congress Presentation
Comparison of apixaban 5 mg vs 2.5 mg for the prevention of cancer-associated venous thromboembolism: A pooled analysis of two studies
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources